Stocks Health care VTAK
NYSE · Health careCatheter Precision, Inc. (VTAK)
Catheter Precision, Inc. brought in $1.9M of revenue over the twelve months to June 30, 2026, up 219.2% from a year earlier. It posted a net loss of $13M. In fiscal 2025 capital spending exceeded operating cash flow by $8.3M. At June 30, 2026 it held $643K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
What Catheter Precision, Inc. does
Catheter Precision, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker VTAK.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $819K | -$17.2M | -$15.90 | -$8.3M |
| 2024 | $420K | -$16.6M | -$126.91 | -$9.3M |
| 2023 | $442K | -$70.6M | -$2,467.53 | -$20.7M |
| 2022 | $14K | -$26.9M | -$493.58 | -$22.6M |
| 2021 | $22K | -$25.1M | -$4,715.81 | -$27.9M |
| 2020 | $4.4M | -$36M | -$20,175.29 | -$28.4M |
Where VTAK ranks in Health care
Latest SEC filings
What Catheter Precision, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 25, 2026Other event 8-K
- August 31, 2026Proxy statement DEF 14A
- August 21, 2026
- August 21, 2026Preliminary proxy statement PRE 14A
- August 21, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 381% to $1M versus the same quarter last year; diluted EPS -$0.92 versus -$7.28.
- July 31, 2026
- July 29, 2026Exhibits 8-K/A
- July 20, 2026Passive stake (5% or more) SCHEDULE 13G
- July 15, 2026
Who owns VTAK
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| C/M Capital Partners, LP13G, passive with 4 related filers | 9.99% | August 21, 2026 |
| Seg Jets Spv I, LLC13G, passive | 9.79% | July 20, 2026 |
| Gregory Castaldo13G, passive | 7.5% | February 11, 2026 |
| Joseph Reda13G, passive | 7.5% | February 11, 2026 |
Largest institutional holders
Insiders
Questions about VTAK
What does Catheter Precision, Inc. do?
Catheter Precision, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker VTAK.
Is Catheter Precision, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $13M on revenue of $1.9M.
How much revenue does Catheter Precision, Inc. make?
Over the twelve months to June 30, 2026 Catheter Precision, Inc. reported revenue of $1.9M. That is 219.2% more than a year earlier.
When did Catheter Precision, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 25, 2026.
Similar companies
Compare VTAK with
Follow VTAK
Get an email when Catheter Precision, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow VTAK: get an email when it filesWhere the numbers come from
Financial figures are the values Catheter Precision, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.